Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: J Am Coll Surg. 2011 Apr 13;213(2):306–316. doi: 10.1016/j.jamcollsurg.2011.03.013

Table 4.

Toxicity for First Time and Repeat Treatments

CTCAE < 3 CTCAE ≥ 3
First HILP (n = 62) 45 (73%) 17 (27%)
First ILI (n = 122) 98 (80%) 24 (20%)
ILI after ILI (n = 16) 11 (69%) 5 (31%)
HILP after ILI (n = 7) 3 (43%) 4 (57%)
ILI after HILP (n = 2) 2 (100%) 0 (0%)
HILP after HILP (n = 3) 3 (100%) 0 (0%)

CTCAE, Common Terminology Criteria for Adverse Events; HILP, hyperthermic isolated limb perfusion; ILI, isolated limb infusion.